首页 > 市场调查报告书 > 医疗设备

纤维

市场调查报告书

商品编码

1900248

生物医用纺织品市场规模、份额和成长分析（按纤维类型、织物类型、产品类型、应用和地区划分）－2026-2033年产业预测

Biomedical Textiles Market Size, Share, and Growth Analysis, By Fiber Type (Non-Biodegradable, Biodegradable), By Fabric Type (Woven, Non-Woven), By Product Type, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生物医学纺织品市场规模将达到 189.2 亿美元，到 2025 年将达到 201.9 亿美元，到 2033 年将达到 339.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.7%。

由于人们对医疗技术进步的认识不断提高，以及对医用服装的需求日益增长，生物医用纺织品市场正经历着显着增长。推动市场发展的关键因素包括人造牙齿、身体增强解决方案和人工植牙等医疗矫正器具的日益普及。人口老化加剧也对市场产生影响，尤其体现在膝关节关节重建手术数量的增加以及由此带来的植入需求成长。此外，对OK绷、纱布等创伤护理产品以及整形外科植入的需求不断增长，也推动了市场发展。其他因素还包括慢性病发病率上升、都市化进程加快、发展中地区医疗保健成本不断上涨，以及生活方式的改变和可支配收入的增加。

生物医用纺织品市场驱动因素

由于医疗专业人员越来越多地采用生物医用服装来修復或取代受损的身体部位，生物医用纺织品市场正在蓬勃发展。这些创新纤维被广泛应用于各种领域，包括合成组织、纤维和移植材料，从而显着推动了医疗程序的进步。例如，合成纤维植入可以作为人工动脉和血管，有效解决心血管系统的阻塞和薄弱环节。此外，医用级纤维在各种整形外科应用中也至关重要，例如缝线、关节和肌腱移植、重组装置以及脊椎敷料，这些都显着改善了患者的治疗效果和復原过程。

生物医用纺织品市场的限制因素

生物医用纺织品市场面临许多挑战，可能阻碍其发展。开发这些专为抵御各种健康威胁而设计的尖端材料需要大量的研发投入和相关成本。劳动力、技术专长和其他生产要素的高昂成本可能构成重大障碍。此外，使用聚酯、棉、聚丙烯、聚氨酯和乙烯基等合成材料增加了製造流程的复杂性，并需要大量投资，这可能会阻碍新进入者进入市场。这些资金限制最终可能会限制创新和专业生物医用纺织品的扩张。

生物医用纺织品市场趋势

受对先进医疗解决方案日益增长的需求驱动，生物医用纺织品市场正经历显着增长。医疗保健服务的扩展和医学素养的提高，为生物製药和医用纺织品领域的创新创造了有利环境。意外事故、文明病和感染疾病的发生率上升，进一步凸显了对能够提高患者照护和治疗效率的先进医用纺织品的需求。为了应对这些挑战，并随着医疗保健预算的不断增加，製造商正利用生物医用纺织品领域的技术进步，在不断变化的医疗产业格局中占据战略优势。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Royal DSM（Netherlands）
Johnson & Johnson（United States）
Medtronic（United States）
Cardinal Health（United States）
Integra LifeSciences Corporation（United States）
Smith & Nephew（United Kingdom）
Medline（United States）
Paul Hartmann AG（Germany）
BSN Medical（Germany）
ATEX Technologies（United States）
Elkem Silicones（Germany）
Bally Ribbon Mills（United States）
US Biodesign（United States）
Nitto Denko Corporation（Japan）
Kimberly-Clark（United States）
Molnlycke Health Care（Sweden）
3M Company（United States）
Ahlstrom-Munksjo（Sweden）
Freudenberg & Co. Kommanditgesellschaft（Germany）
Secant Group LLC（United States）

结论与建议

简介目录

Product Code: SQMIG15A2431

Biomedical Textiles Market size was valued at USD 18.92 Billion in 2024 and is poised to grow from USD 20.19 Billion in 2025 to USD 33.91 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The biomedical textiles market is experiencing significant growth due to heightened awareness of healthcare advancements and the demand for medically suitable apparel. Key market drivers include a rising prevalence of medical dressings, such as artificial teeth, body augmentation solutions, and dental implants. The expansion of the geriatric population is also influencing the market, particularly as it correlates with an uptick in knee joint replacement surgeries and the subsequent demand for implants. Additionally, the soaring need for wound care products like plasters and gauze, alongside orthopedic implants, is propelling market development. Other contributing factors include an increase in chronic conditions, urbanization, and rising healthcare costs in developing regions, combined with changing lifestyles and growing disposable incomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biomedical Textiles market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biomedical Textiles Market Segments Analysis

Global Biomedical Textiles Market is segmented by Fiber Type, Fabric Type, Product Type, Application and region. Based on Fiber Type, the market is segmented into Non-Biodegradable and Biodegradable. Based on Fabric Type, the market is segmented into Woven and Non-Woven. Based on Product Type, the market is segmented into Non-Implantable and Implantable. Based on Application, the market is segmented into Dentistry, General Surgery & Treatment, Ophthalmology, Neurology, Cardiology, Orthopedics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biomedical Textiles Market

The Biomedical Textiles market is experiencing growth due to the rising adoption of biomedical garments by healthcare professionals for enhancing and replacing damaged body parts. These innovative textiles have a wide-ranging application in synthetic tissues, fibers, and grafts, enabling significant advancements in medical procedures. For instance, synthetic fabric implants serve as artificial arteries or vessels, effectively addressing blockages or weaknesses in the cardiovascular system. Additionally, pharmaceutical textiles are essential in various orthopedic applications, including sutures, joint and tendon grafts, reconstructive devices, and spinal dressings, thereby significantly improving patient outcomes and recovery processes in the healthcare sector.

Restraints in the Biomedical Textiles Market

The Biomedical Textiles market faces several challenges that can hinder its growth. The extensive research and development necessary for creating these advanced materials, which are specifically engineered to resist various health-related threats, incurs significant costs. The high expenses associated with labor, technical expertise, and other production factors can be a substantial barrier. Furthermore, the use of synthetic materials like polyester, cotton, polypropylene, polyurethane, and vinyl adds complexity to the manufacturing process, requiring large investments that may deter potential entrants to the market. These financial constraints can ultimately limit innovation and the expansion of specialized biomedical textile products.

Market Trends of the Biomedical Textiles Market

The Biomedical Textiles market is experiencing significant growth driven by the rising demand for advanced healthcare solutions. The expansion of healthcare services, coupled with heightened healthcare literacy, is fostering an environment conducive to innovation in biopharmaceuticals and medical textiles. Increasing rates of accidents, lifestyle-related diseases, and infectious conditions further amplify the need for sophisticated medical textiles that enhance patient care and procedural effectiveness. As healthcare budgets continue to rise, manufacturers are poised to leverage technological advancements in biomedical textiles to address these challenges, positioning themselves strategically within the evolving landscape of the healthcare industry.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Biomedical Textiles Market Size by Fiber Type & CAGR (2026-2033)

Market Overview
Non-Biodegradable
Biodegradable

Global Biomedical Textiles Market Size by Fabric Type & CAGR (2026-2033)

Market Overview
Woven
Non-Woven

Global Biomedical Textiles Market Size by Product Type & CAGR (2026-2033)

Market Overview
Non-Implantable
Implantable

Global Biomedical Textiles Market Size by Application & CAGR (2026-2033)

Market Overview
Dentistry
General Surgery & Treatment
Ophthalmology
Neurology
Cardiology
Orthopedics
Others

Global Biomedical Textiles Market Size & CAGR (2026-2033)

North America (Fiber Type, Fabric Type, Product Type, Application)
- US
- Canada
Europe (Fiber Type, Fabric Type, Product Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Fiber Type, Fabric Type, Product Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Fiber Type, Fabric Type, Product Type, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Fiber Type, Fabric Type, Product Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Royal DSM (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paul Hartmann AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSN Medical (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATEX Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elkem Silicones (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bally Ribbon Mills (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
US Biodesign (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nitto Denko Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimberly-Clark (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ahlstrom-Munksjo (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Freudenberg & Co. Kommanditgesellschaft (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Secant Group LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments